Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Optima Pharma, Charité Initiate Cell Production Platform Project | Contract Pharma

What are you searching for?

Sign in

Optima Pharma, Charité Initiate Cell Production Platform Project

Aims to develop a production platform for automatic manufacturing and filling of cell and gene therapeutics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

In a pilot project, Optima Pharma and Charité – Universitätsmedizin Berlin are developing a production platform for the automatic manufacturing and filling of cell and gene therapeutics. These new types of medicine are paving the way for personalized medicine and are considered a promising new therapy possibility for hereditary and metabolic diseases, neurodegenerative disorders, and cancer. These medications depend on the patient’s cells and are still produced manually, for each individual patient, which is very expensive. The new project is financed by the Berlin Institute of Health (BIH).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics